跳至主要内容
临床试验/CTRI/2024/05/067562
CTRI/2024/05/067562尚未招募Unknown

A Clinical Study To Determine the In-Vivo Sun Protection Factor of Sri Sri Tattva Sunscreen 2A

Sri Sri Tattva Pvt Ltd1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2024年5月27日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
10
试验地点
1
主要终点
Change in Individual MED (iMED) score

研究概览

简要总结

The below products would be tested as per the guidelineInternational Standard ISO 24444 and ISO 16217 Product Name Sunscreen 2A

The study would be to estimate the SPF- sun protection factor

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Voluntary man or women between 18 and 65 years.
  • Photo type III to V.
  • Having apparently healthy skin on test area
  • For whom the investigator considers that the compliance will be correct.
  • Cooperating, informed of the need and duration of the examinations and ready to comply with protocol procedures.
  • Having signed a Consent Form.
  • Willingness to avoid intense UV exposure on test site (sun or artificial UV), during the course of the study.
  • Willingness to avoid excessive water contact (for example swimming) or activity which causes excessive sweating (that is exercise, sauna), during the course of the study.
  • Should be able to read and write (in English, Hindi or local language).
  • Having valid proof of identity and age.

排除标准

  • 1.Pregnant or nursing mothers 2.Scars, excessive terminal hair or tattoo on the studied area.
  • 3.Henna tattoo anywhere on the body (in case of studies involving hair dyes).
  • 4.Dermatological infection or pathology on the level of studied area.
  • 5.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye).
  • 6.Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures.
  • 7.Chronic illness which may influence the outcome of the study.
  • 8.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month).
  • 9.Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial.

结局指标

主要结局

Change in Individual MED (iMED) score

时间窗: Day 1 and Day 2

次要结局

  • Change in the redness of skin(Delayed Erythema Response)

研究者

发起方
Sri Sri Tattva Pvt Ltd
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Robin Chugh

CCFT Laboratories

研究点 (1)

Loading locations...

相似试验